Anaplastic thyroid cancer (ATC) is an infrequent thyroid tumor that usually occurs in elderly
patients. There is often a history of previous differentiated thyroid cancer suggesting a …

Anaplastic thyroid cancer (ATC) is a rare but highly aggressive kind of thyroid cancer.
Various therapeutic methods have been considered for the treatment of ATC, but its …

Background: The dabrafenib plus trametinib combination (DT) has revolutionized the
treatment of BRAFV600E-mutated anaplastic thyroid carcinoma (BRAFm-ATC). However …

Importance BRAF/MEK inhibitors revolutionized the treatment ofBRAFV600E-variant
anaplastic thyroid carcinoma (BRAFv-ATC), offering improved outcomes for patients with this …

Simple Summary Radioactive iodine treatment is the oldest targeted therapy for
differentiated thyroid cancer. It can be used for normal thyroid remnant ablation (in order to …

Well-differentiated thyroid carcinoma has a favorable prognosis with a 5-year survival rate of
over 95%. However, the undifferentiated or anaplastic type accounting for< 0.2%, usually in …

Introduction Vitamin C (ascorbic acid) is a water‐soluble vitamin, that plays a key role in the
prevention and treatment of scurvy. As vitamin C is an antioxidant and thyroid function may …

Objectives Anaplastic thyroid carcinoma (ATC) has a poor survival. The combination of
Dabrafenib plus Trametinib (DT) had a significant impact in survival of BRAF p. V600E …

Background: Anaplastic thyroid carcinoma (ATC) is a rare and frequently fatal type of thyroid
cancer. The degree of heterogeneity in survival rates for ATC is incompletely studied. This …

Introduction Anaplastic thyroid cancer (ATC) is one of the most lethal diseases known to
humans with a median survival of 5 months. The American Thyroid Association (ATA) …